AKT

Open Access
Akt Regulates Extracellular Vesicle Secretion in Hypoxia-adapted Multiple Myeloma RPMI8226 Cells
YUKI TODA, SAYAKA NAKAYAMA, YUNA YAMAMOTO, ASUKA FUJIMOTO, SHIGEKUNI HOSOGI and EISHI ASHIHARA

Anticancer Research April 2025, 45 (4) 1355-1366; DOI: https://doi.org/10.21873/anticanres.17521
Open Access
Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics
MAKITO MOTOYAMA, RYOTA SHIGEFUKU, NORIYOSHI TANAKA, MITSUAKI NISHIZAWA, KEIGO OSHIO, YOSHITOMO SUHARA and ICHIRO YAJIMA

Anticancer Research February 2025, 45 (2) 433-443; DOI: https://doi.org/10.21873/anticanres.17432
Open Access
Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression
YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research July 2024, 44 (7) 2787-2792; DOI: https://doi.org/10.21873/anticanres.17090
You have access
A Potential Combination of Targeting HSP90 and mTOR in Breast Cancer Cell Growth, Migration, and Invasion Through Inhibiting AKT Phosphorylation and F-actin Organization
PRASIT SUWANNALERT, PIMCHANOK PANPINYAPORN, PITCHAPA WANTANACHAISAENG, TEERAPAT TEEPPAIBUL, WILUNPLUS KHUMSRI, THIDARAT KOOMSANG, WITCHUDA PAYUHAKRIT and CHONNAPAT NAKTUBTIM

Anticancer Research June 2024, 44 (6) 2555-2565; DOI: https://doi.org/10.21873/anticanres.17061
You have access
Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells
CHUN-YI LI, HSIN-CHUAN CHEN, CHIH-YING LIAO, FEI-TING HSU, KUANG-CHEN HUNG, KUO-CHING LIU, JAW-CHYUN CHEN and MING-CHOU KU

Anticancer Research January 2024, 44 (1) 85-92; DOI: https://doi.org/10.21873/anticanres.16790
You have access
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors
YU JIN KIM, SE-KYEONG JANG, GYEONGMI KIM, SUNG-EUN HONG, CHAN SUB PARK, MIN-KI SEONG, HYUN-AH KIM, KWANG SEOK KIM, CHUN-HO KIM, KI SOO PARK, JUNGIL HONG, HYEON-OK JIN and IN-CHUL PARK

Anticancer Research May 2023, 43 (5) 1973-1980; DOI: https://doi.org/10.21873/anticanres.16357
You have access
LQB-118 Suppresses Migration and Invasion of Prostate Cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression
THIAGO MARTINO, GRAZIELE FREITAS DE BEM, SHIRLEY VANIA MOURA SANTOS, MARSEN GARCIA PINTO COELHO, ANGELA DE CASTRO RESENDE, CHAQUIP NETTO, PAULO ROBERTO RIBEIRO COSTA, GRAÇA JUSTO and KATIA COSTA DE CARVALHO SABINO

Anticancer Research January 2023, 43 (1) 359-367; DOI: https://doi.org/10.21873/anticanres.16171
You have access
Knockdown of NUPR1 Enhances the Sensitivity of Non-small-cell Lung Cancer Cells to Metformin by AKT Inhibition
YU JIN KIM, SUNG-EUN HONG, SE-KYEONG JANG, KI SOO PARK, CHUN-HO KIM, IN-CHUL PARK and HYEON-OK JIN

Anticancer Research July 2022, 42 (7) 3475-3481; DOI: https://doi.org/10.21873/anticanres.15834
You have access
Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib
CHE-JUI YANG, MENG-HSUAN WU, JAI-JEN TSAI, FEI-TING HSU, TE-CHUN HSIA, KUO-CHING LIU and YU-CHENG KUO

Anticancer Research May 2022, 42 (5) 2495-2505; DOI: https://doi.org/10.21873/anticanres.15728
You have access
Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells
HIROMITSU WATANABE, ASUKA KAWAKAMI, RYO SATO, KYOHEI WATANABE, YUTO MATSUSHITA and HIDEAKI MIYAKE

Anticancer Research August 2021, 41 (8) 3753-3758; DOI: https://doi.org/10.21873/anticanres.15167

Main menu

User menu

Search

AKT

Pages